arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2409.18879q-bio.PEq-bio.QM
收藏

一种从药物筛选中检测治疗诱导耐药性的统计框架

A statistical framework for detecting therapy-induced resistance from drug screens

Chenyu Wu, Einar Bjarki Gunnarsson, Jasmine Foo, Kevin Leder

AI总结:

本研究提出基于多类型分支过程模型的统计框架,从高通量药物筛选数据中检测并量化癌症治疗诱导的耐药性,通过模拟与体外实验验证了其有效性。

摘要:

治疗耐药性仍然是癌症治疗中的一个重大挑战,这通常是由于存在干细胞样细胞群,这些细胞群驱动了治疗后的肿瘤复发。此外,许多抗癌疗法会诱导细胞可塑性,将最初对药物敏感的细胞转化为更具耐药性的状态,例如通过表观遗传过程和去分化程序。理解治疗抗肿瘤效应与诱导耐药性之间的平衡对于确定治疗策略至关重要。在本研究中,我们引入了一个稳健的统计框架,该框架基于肿瘤细胞群进化动力学的多类型分支过程模型,用于从高通量药物筛选数据中检测和量化治疗诱导的耐药现象。通过全面的计算机模拟实验,我们展示了我们的框架在估计异质性肿瘤群体中控制群体动力学和药物反应的参数方面的有效性,在该群体中,细胞状态的转变受到药物的影响。最后,使用来自多个来源的最新体外数据,我们证明我们的框架对于分析真实世界数据和生成有意义的预测是有效的。

英文摘要:

Resistance to therapy remains a significant challenge in cancer treatment, often due to the presence of a stem-like cell population that drives tumor recurrence post-treatment. Moreover, many anticancer therapies induce plasticity, converting initially drug-sensitive cells to a more resistant state, e.g. through epigenetic processes and de-differentiation programs. Understanding the balance between therapeutic anti-tumor effects and induced resistance is critical for identifying treatment strategies. In this study, we introduce a robust statistical framework, based on multi-type branching process models of the evolutionary dynamics of tumor cell populations, to detect and quantify therapy-induced resistance phenomena from high throughput drug screening data. Through comprehensive in silico experiments, we show the efficacy of our framework in estimating parameters governing population dynamics and drug responses in a heterogeneous tumor population where cell state transitions are influenced by the drug. Finally, using recent in vitro data from multiple sources, we demonstrate that our framework is effective for analyzing real-world data and generating meaningful predictions.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑